Detection of clinically significant prostate cancer using targeted MRI-informed microultrasound biopsy.
2/5 보강
TL;DR
This retrospective study demonstrates successful implementation of microUS-guided biopsy, with similar rates of identification of csPCa compared to historical data using mpMRI-US fusion, supporting the combined approach of these techniques.
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
169 subjects and 244 total lesions were identified by mpMRI.
I · Intervention 중재 / 시술
mpMRI-informed microultrasound-guided (microUS) biopsy was performed
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Findings Identification of clinically significant prostate cancer by microUS-guided biopsy was similar to mpMRI-US fusion biopsy, suggesting microUS-guided biopsy performs as well as mpMRI-US fusion biopsy. Clinical relevance Our study shows the complementary role of mpMRI and microUS for the detection of clinically significant prostate cancer, supporting the combined approach of these techniques.
OpenAlex 토픽 ·
Prostate Cancer Diagnosis and Treatment
Ultrasound and Hyperthermia Applications
Fetal and Pediatric Neurological Disorders
This retrospective study demonstrates successful implementation of microUS-guided biopsy, with similar rates of identification of csPCa compared to historical data using mpMRI-US fusion, supporting th
- p-value p < 0.05
APA
Allison B. Forrest, Danielle E. Kruse, et al. (2026). Detection of clinically significant prostate cancer using targeted MRI-informed microultrasound biopsy.. European radiology, 36(5), 3408-3417. https://doi.org/10.1007/s00330-025-12136-5
MLA
Allison B. Forrest, et al.. "Detection of clinically significant prostate cancer using targeted MRI-informed microultrasound biopsy.." European radiology, vol. 36, no. 5, 2026, pp. 3408-3417.
PMID
41273426 ↗
Abstract 한글 요약
[OBJECTIVES] This study compares the rate of detection of clinically significant prostate cancer (csPCa) using multiparametric MRI (mpMRI)-informed microultrasound-guided (microUS) biopsy to historical published data using mpMRI-ultrasound (mpMRI-US) fusion biopsy at the same institution.
[MATERIALS AND METHODS] A single-center retrospective study of patients who underwent mpMRI-informed microultrasound-guided (microUS) biopsy was performed. Positive predictive value (PPV) of targeted lesions by PI-RADS and PRI-MUS (Prostate Risk Identification Using Microultrasound) was calculated and compared to published data using an mpMRI-US fusion platform.
[RESULTS] 169 subjects and 244 total lesions were identified by mpMRI. 44/244 (18.0%), 167/244 (68.4%), and 33/244 (13.5%) were PI-RADS 5, 4, and 3, respectively. 206/244 (84.4%) lesions seen on mpMRI were identified on microUS. 26 additional lesions were identified by microUS only. PCa was identified in 120/169 (71.0%) patients, and csPCa was identified in 70/169 (41.4%) by targeted microUS-guided biopsy of MRI lesions. Targeted biopsy of lesions seen only on microUS added three cases of csPCa (73/169, 43.2%). PPV of targeted PI-RADS 5, 4, and 3 lesions for all PCa and csPCa was 0.80, 0.61, and 0.39, and 0.64, 0.31, and 0.12, respectively. Findings were not significantly different compared to historical data using mpMRI-US fusion biopsy (p > 0.05). PPV for csPCa was 0.18 for mpMRI lesions when no correlate was identified by microUS, compared to 0.37 for lesions when a correlate was seen (p < 0.05).
[CONCLUSIONS] This retrospective study demonstrates successful implementation of microUS-guided biopsy, with similar rates of identification of csPCa compared to historical data using mpMRI-US fusion.
[KEY POINTS] Question There is limited real-world comparison of the rate of detection of clinically significant prostate cancer using mpMRI-informed microUS-guided biopsy compared to historical mpMRI-ultrasound fusion biopsy. Findings Identification of clinically significant prostate cancer by microUS-guided biopsy was similar to mpMRI-US fusion biopsy, suggesting microUS-guided biopsy performs as well as mpMRI-US fusion biopsy. Clinical relevance Our study shows the complementary role of mpMRI and microUS for the detection of clinically significant prostate cancer, supporting the combined approach of these techniques.
[MATERIALS AND METHODS] A single-center retrospective study of patients who underwent mpMRI-informed microultrasound-guided (microUS) biopsy was performed. Positive predictive value (PPV) of targeted lesions by PI-RADS and PRI-MUS (Prostate Risk Identification Using Microultrasound) was calculated and compared to published data using an mpMRI-US fusion platform.
[RESULTS] 169 subjects and 244 total lesions were identified by mpMRI. 44/244 (18.0%), 167/244 (68.4%), and 33/244 (13.5%) were PI-RADS 5, 4, and 3, respectively. 206/244 (84.4%) lesions seen on mpMRI were identified on microUS. 26 additional lesions were identified by microUS only. PCa was identified in 120/169 (71.0%) patients, and csPCa was identified in 70/169 (41.4%) by targeted microUS-guided biopsy of MRI lesions. Targeted biopsy of lesions seen only on microUS added three cases of csPCa (73/169, 43.2%). PPV of targeted PI-RADS 5, 4, and 3 lesions for all PCa and csPCa was 0.80, 0.61, and 0.39, and 0.64, 0.31, and 0.12, respectively. Findings were not significantly different compared to historical data using mpMRI-US fusion biopsy (p > 0.05). PPV for csPCa was 0.18 for mpMRI lesions when no correlate was identified by microUS, compared to 0.37 for lesions when a correlate was seen (p < 0.05).
[CONCLUSIONS] This retrospective study demonstrates successful implementation of microUS-guided biopsy, with similar rates of identification of csPCa compared to historical data using mpMRI-US fusion.
[KEY POINTS] Question There is limited real-world comparison of the rate of detection of clinically significant prostate cancer using mpMRI-informed microUS-guided biopsy compared to historical mpMRI-ultrasound fusion biopsy. Findings Identification of clinically significant prostate cancer by microUS-guided biopsy was similar to mpMRI-US fusion biopsy, suggesting microUS-guided biopsy performs as well as mpMRI-US fusion biopsy. Clinical relevance Our study shows the complementary role of mpMRI and microUS for the detection of clinically significant prostate cancer, supporting the combined approach of these techniques.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- Male
- Prostatic Neoplasms
- Retrospective Studies
- Aged
- Middle Aged
- Image-Guided Biopsy
- Multiparametric Magnetic Resonance Imaging
- Ultrasonography
- Interventional
- Magnetic Resonance Imaging
- Predictive Value of Tests
- Prostate
- Image-guided biopsy
- Multiparametric magnetic resonance imaging
- Prostate cancer
- Ultrasound
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.